StellarPGx:基于Nextflow的CYP基因星等位基因检测流程
StellarPGx是一款基于Nextflow的开源流程,结合基因组图变异检测、原始参考比对覆盖信息与组合双体型判定,用于CYP基因星等位基因分型。以CYP2D6为模型基因,在109例全基因组测序样本中,其与GeT-RM共识双体型的一致率为99%,高于Cyrius(98%)、Aldy(82%)和Stargazer(84%)。
要点
- StellarPGx可对CYP1、2、3家族的12个药物基因进行星等位基因分型。
- 在109例样本中CYP2D6双体型一致率达99%,优于对比的三种工具。
- 流程开源、可移植且可复现,适用于研究与临床药物基因组学。
核心结论
- StellarPGx在109例全基因组测序样本中对CYP2D6双体型的分型与GeT-RM共识一致率达99%,显示其用于CYP基因分型的高准确性。
研究设计与样本
- 研究构建了基于Nextflow的开源流程StellarPGx,并在109例有GeT-RM共识CYP2D6双体型的全基因组测序样本中与三种现有工具进行比较验证。
主要发现
- StellarPGx的CYP2D6双体型一致率为99%,Cyrius为98%,Aldy为82%,Stargazer为84%,均以GeT-RM共识为参照。
- StellarPGx目前可对CYP1、2、3家族的12个重要药物基因进行分型。
- CYP2D6已定义超过130个星等位基因,并包含复杂结构变异。
关键数值与推荐
- CYP2D6双体型一致率:StellarPGx 99%、Cyrius 98%、Aldy 82%、Stargazer 84%(对比对象为GeT-RM共识,样本109例)。
- CYP2D6已定义星等位基因超过130个。
临床怎么用
- 可考虑将StellarPGx用于CYP基因的星等位基因分型,为药物基因组学检测与精准用药提供基因型依据。
- 流程基于Nextflow实现,便于在不同平台部署与复现。
局限性
- 验证仅以CYP2D6为模型基因,其他CYP基因的分型准确性未在本文中报告。
- 研究对象为109例全基因组测序样本,方法在其他测序类型与人群中的表现未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bioinformatics pipelines for calling star alleles (haplotypes) in cytochrome P450 (CYP) genes are important for the implementation of precision medicine. Genotyping CYP genes using high throughput sequencing data is complicated, e.g., by being highly polymorphic, not to mention the structural variations especially in CYP2D6, CYP2A6, and CYP2B6. Genome graph-based variant detection approaches have been shown to be reliable for genotyping HLA alleles. However, their application to enhancing star allele calling in CYP genes has not been extensively explored. We present StellarPGx, a Nextflow pipeline for accurately genotyping CYP genes by combining genome graph-based variant detection, read coverage information from the original reference-based alignments, and combinatorial diplotype assignments. The implementation of StellarPGx using Nextflow facilitates its portability, reproducibility, and scalability on various user platforms. StellarPGx is currently able to genotype 12 important pharmacogenes belonging to the CYP1, 2, and 3 families. For purposes of validation, we use CYP2D6 as a model gene owing to its high degree of polymorphisms (over 130 star alleles defined to date, including complex structural variants) and clinical importance. We applied StellarPGx and three existing callers to 109 whole genome sequenced samples for which the Genetic Testing Reference Material Coordination Program (GeT-RM) has recently provided consensus truth CYP2D6 diplotypes. StellarPGx had the highest CYP2D6 diplotype concordance (99%) with GeT-RM compared with Cyrius (98%), Aldy (82%), and Stargazer (84%). This exemplifies the high accuracy of StellarPGx and highlights its importance for both research and clinical pharmacogenomics applications. The StellarPGx pipeline is open-source and available from https://github.com/SBIMB/StellarPGx.
引用
- Twesigomwe D, Drögemöller BI, Wright GEB, et al. StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes. Clin Pharmacol Ther. 2021. PMID: 33492672. doi:10.1002/cpt.2173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。